HHS to allocate COVID-19 funds to hospitals in hard-hit areas
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On May 1, the Trump Administration announced that the U.S. Department of Health and Human Services (HHS) would distribute a combined $12 billion in funding to hospitals in areas hit hard by the COVID-19 pandemic. Of the $12 billion total, HHS is expected to disburse $10 billion in funding to 395 hospitals across the country that provided inpatient care for 100 or more COVID-19 patients through April 10, 2020. The agency will distribute an additional $2 billion to these hospitals serving a disproportionate share of low-income and uninsured patients. Funding will also target rural hospitals and Community Health Centers (CHC) located in rural areas.
The $12 billion in new funding comes from the Provider Relief Fund, a $100 billion fund authorized under the Coronavirus Aid, Relief and Economic Security (CARES) Act (P.L. 116-136). This fund supports hospitals and health care facilities by supplying added resources for healthcare related expenses or lost revenue attributable to COVID-19, and ensures that uninsured Americans have access to testing and treatment during the coronavirus pandemic. The new resources for disproportionate share hospitals, known as DSH, represent a key county health priority, as many DSH hospitals are owned and operated by counties. The funding breakdown for states and counties can be found at this link.
In addition to the DSH provisions included under the CARES Act, at the end of April, Congress approved the addition of $75 billion for hospitals and health care providers as part of the Paycheck Protection Program and Health Care Enhancement Act (H.R. 266). HHS is currently working to distribute the original $100 billion to eligible providers, of which $10 billion is expected to go direct to Medicaid providers. Also, under the CARES Act, Congress moved to delay $4 billion in scheduled cuts to DSH payments to help hospitals – including many county-owned hospitals – continue providing high-quality care to all patients.
For additional NACo health policy resources on COVID-19, please see the following links:
- U.S. Senate passes $484 billion coronavirus relief package (NACo blog)
- NACo Analysis of the Third COVID-19 Supplemental Package: The CARES Act (NACo legislative analysis)
- HHS Begins Distribution of Payments to Hospitals with High COVID-19 Admissions, Rural Providers (HHS press release)
Attachments
Related News
SAMHSA releases new 2024 data on rates of mental illness and substance use disorder in the U.S.
On July 28, the U.S. Department of Health and Human Services’ (HHS) Substance Abuse and Mental Health Services Administration (SAMHSA) released the findings of its annual National Survey on Drug Use and Health (NSDUH), which provides data on rates of substance use and mental illness at the national, state and local level.
Congress introduces bipartisan legislation to strengthen rural health care access and funding
Rural communities face unique health care challenges, from provider shortages to funding disparities. To address these concerns, the U.S. Senate recently introduced two bipartisan bills aimed at improving rural health care access and funding: the Rural Health Focus Act and the Fair Funding for Rural Hospitals Act.
HALT Fentanyl Act signed into law
On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.